HHRI News & Press Releases
Thank you to Dr. Jason Baker for his exceptional dedication and service as HHRI Vice President
Jason Baker, MD, MS, recently stepped down as Vice President of Hennepin Healthcare Research Institute (HHRI). Dr. Baker began his tenure as VP in January 2015 when the institute was the Minneapolis Medical Research Foundation and served in the role until December 2021. During this time, Dr. Baker was instrumental…
Read More
CDC study including Hennepin County data finds that people experiencing homelessness had significantly lower vaccination coverage compared to all residents living in the same area
In consultation with public health and housing assistance partners, CDC identified six urban, public health jurisdictions, including Hennepin County, with data on COVID-19 vaccination coverage among people experiencing homelessness. The vaccination data was reported between December 13, 2020 and August 31, 2021. The vaccination coverage and population size for the…
Read More
Increasing Trust is Key to Addressing the COVID-19 Pandemic and Other Threats to Health
As the COVID-19 pandemic continues to threaten the health of communities worldwide, researchers say that patients’ trust in the medical profession has never been more important as the health care community seeks to administer COVID vaccines en masse. Patients’ trust in the medical profession – and clinicians’ trust in their…
Read More
Dr. Winkelman talks about EHR Consortium and COVID-19 on Healthy Matters on WCCO radio
Hennepin Healthcare physician and HHRI researcher Dr. Tyler Winkelman was Dr. David Hilden’s guest Healthy Matters on WCCO 830-AM radio on Sunday, September 26, talking about the Electronic Health Records (EHR) Consortium, COVID-19 vaccinations and stats, health equity, and how Minnesota collaborates. Dr. Winkelman leads the Minnesota consortium. Their mission is to improve health…
Read More
Study identifies racial/ethnic and language inequities in ways patients obtain COVID-19 virus testing
The COVID-19 pandemic caused an unprecedented disruption to health care delivery, with resources shifted toward telehealth services and mass viral testing. While early studies in the pandemic highlighted differences in health care utilization among patients with commercial insurance, data from publicly insured or uninsured “safety-net” patient populations continue to emerge.…
Read More
Walz, Flanagan Announce Groundbreaking Partnership Between State of Minnesota, Health Care Systems on Race and Ethnicity Data Collection
— State announces additional, targeted strategies to promote equity in vaccination — The Walz-Flanagan Administration announced publication of vaccination data by race and ethnicity made possible through the groundbreaking partnership between the State of Minnesota and the Minnesota Electronic Health Record (EHR) Consortium. This unique and innovative collaboration between public…
Read More
Hennepin Healthcare takes a pulse of the pandemic
by hennepinmedical — COVID-19’s rapid arrival in Minnesota in March 2020 created myriad changes across the community – and a snapshot of that impact is now available in a report from Hennepin Healthcare. A collaboration for quality improvement between Hennepin Healthcare and Hennepin Healthcare Research Institute (HHRI) emerged to design…
Read More
Hennepin Healthcare collaborates with Mayo Clinic on convalescent plasma protocol as a therapeutic treatment for COVID-19 patients
Minneapolis, Minn. – Hennepin Healthcare Research Institute (HHRI) is collaborating with the Mayo Clinic to engage in a clinical protocol using convalescent plasma as a therapeutic treatment for COVID-19 patients. Convalescent plasma has appeared to be of benefit for the treatment of certain infectious diseases, including infections from respiratory viruses.…
Read MoreImmune Therapy and Immunology
Our Research Home » Our Research » Immune Therapy and Immunology The COVID-19 pandemic has had a dramatically destructive effect on the social, economic and physical health of our global society. With a tradition of excellence in clinical research, extensive experience treating underserved populations, and an unparalleled expertise in critical…
Read More
Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan
Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…
Read More
Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19
Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Hennepin Healthcare is a clinical site…
Read More